INNOVACAP logo

Innova Captab Limited Stock Price

NSEI:INNOVACAP Community·₹48.5b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 12 Fair Values set on narratives written by author

INNOVACAP Share Price Performance

₹848.30
-42.20 (-4.74%)
₹891.50
Fair Value
₹848.30
-42.20 (-4.74%)
4.8% undervalued intrinsic discount
₹891.50
Fair Value
Price ₹848.30
AnalystConsensusTarget ₹891.50

INNOVACAP Community Narratives

·
Fair Value ₹891.5 4.8% undervalued intrinsic discount

New Jammu Facility Will Capture Global Healthcare Demand

0users have liked this narrative
0users have commented on this narrative
8users have followed this narrative
₹891.5
4.8% undervalued intrinsic discount
Revenue
22.34% p.a.
Profit Margin
11.38%
Future PE
24.14x
Price in 2029
₹1.32k

Trending Discussion

Updated Narratives

INNOVACAP logo

INNOVACAP: Stable Fair Value Assumptions Will Support Bullish Price Re Rating

Fair Value: ₹891.5 4.8% undervalued intrinsic discount
8 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Excellent balance sheet with reasonable growth potential.

0 Risks
2 Rewards

Innova Captab Limited Key Details

₹16.4b

Revenue

₹10.5b

Cost of Revenue

₹5.8b

Gross Profit

₹4.4b

Other Expenses

₹1.4b

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
24.63
35.70%
8.61%
31.4%
View Full Analysis

About INNOVACAP

Founded
2005
Employees
n/a
CEO
Vinay Lohariwala
WebsiteView website
innovacaptab.com

Innova Captab Limited, an integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs in India and internationally. The company provides contract development and manufacturing organization services to Indian pharmaceutical companies. It is also offers various generic formulation products, including cephalosporins, proton pump inhibitor, anticholinergic and heparin NSAIDs, analgesics and antipyretic, anticold and antiallergic, antiemetic, antidiabetic, antispasmodic, antifibrinolytic, cardiovascular, antioxidant and vitamins, antihyperuricemia and antigout, fluoroquinolone and macrolide, nootropics and neurotonics/neurotrophics, antiulcerative, antimalarial anxiolytic, anticonvulsant and antipsychotic, bladder and prostate disorder, antifungal, anthelmintic and antiviral, anticholinergic, anti-asthmatic, and bronchodilator products in the form of tablets, capsules, dry syrups, dry powder injection, ointments, and liquid orals. The company sells its branded generic products through a network of distributors and pharmacies, as well as online channels in various e-commerce pharmacy sites. Innova Captab Limited was incorporated in 2005 and is based in Panchkula, India.

Recent INNOVACAP News & Updates

Analysis Article May 12

Innova Captab Limited (NSE:INNOVACAP) Analysts Are Pretty Bullish On The Stock After Recent Results

As you might know, Innova Captab Limited ( NSE:INNOVACAP ) recently reported its yearly numbers. It was a workmanlike...
Analysis Article May 09

If EPS Growth Is Important To You, Innova Captab (NSE:INNOVACAP) Presents An Opportunity

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

Recent updates

No updates